![]() |
市場調查報告書
商品編碼
1671988
益智藥市場按形式、通路和地區分類Nootropics Market, By Form (Capsules/Tablets, Powder, Drinks, and Others), By Distribution Channel (Offline and Online), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa) |
2025 年全球益智藥市場規模估計為 41.7 億美元,預計到 2032 年將達到 103.7 億美元,2025 年至 2032 年的年複合成長率(CAGR)為 13.9%。
報告範圍 | 報告詳細資訊 | ||
---|---|---|---|
基準年 | 2024 | 2025 年市場規模 | 41.7億美元 |
效能資料 | 從 2020 年到 2024 年 | 預測期 | 2025 至 2032 年 |
預測期:2025-2032年複合年成長率: | 13.90% | 2032 年價值預測 | 103.7億美元 |
過去幾年,隨著人們對增強認知功能的補充劑的認知不斷提高,全球益智藥市場一直在穩步成長。益智藥,也稱為智慧藥物,是一種旨在改善大腦功能和促進神經可塑性的物質。人們對認知能力和心理健康的關注度不斷提高,促使許多人開始尋找自然和替代的方法來增強大腦功能。此外,忙碌的生活方式和日益增加的工作量也帶來了對認知支持的需求,尤其是對專業人士而言。因此,含有 L-茶氨酸、咖啡因、過長沙馬齒莧和絲胺酸等化合物的益智補充劑在世界各地獲得了廣泛支持。此外,老年人口的不斷成長,更容易患神經退化性疾病,這可能在未來幾年繼續增加對益智藥的需求。
全球益智藥市場受到日益成長的健康和保健趨勢、忙碌的生活方式以及對認知表現的日益關注的推動。然而,缺乏臨床證據、嚴格的法規以及某些化合物的潛在副作用限制了市場的成長。人口老化的活性化和研發活動的增加將為市場提供重大機會。壓力、焦慮和憂鬱症導致的精神健康問題的增加推動了對支持大腦健康的補充劑的需求。此外,輸送系統的進步和新化合物的引入進一步擴大了市場範圍。然而,劑量和與其他藥物相互作用的模糊性帶來了重大挑戰。
本研究的主要特點
本報告對全球益智藥市場進行了詳細分析,並提供了預測期(2025-2032 年)的市場規模(十億美元)和年複合成長率(CAGR%),假設基準年為 2024 年。
它還強調了各個領域的潛在商機並解釋了該市場的有吸引力的投資提案矩陣。
它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
它根據公司亮點、產品系列、關鍵亮點、財務業績和策略等參數,對全球益智藥市場的主要企業進行了概述。
主要公司包括 Onnit Labs, Inc.、Qualia (Neurohacker Collective)、Nootrobox、Mind Lab Pro、Alpha Brain、Genius Consciousness、HVMN、Nootropics Depot、Neurohacker Collective、Clevor、BrainMD、Herbalife Nutrition Ltd.、NOW Foods、Gaia Herbs 和 Prometh制。
本報告的見解可以幫助負責人和公司經營團隊就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
本研究報告針對該產業的各個相關人員,包括投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過分析全球益智藥市場所使用的各種策略矩陣來簡化決策。
Global Nootropics Market is estimated to be valued at US$ 4.17 Bn in 2025 and is expected to reach US$ 10.37 Bn by 2032, growing at a compound annual growth rate (CAGR) of 13.9% from 2025 to 2032.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2024 | Market Size in 2025: | US$ 4.17 Bn |
Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
Forecast Period 2025 to 2032 CAGR: | 13.90% | 2032 Value Projection: | US$ 10.37 Bn |
The global nootropics market has been witnessing steady growth over the past few years owing to the increasing awareness about cognitive enhancing supplements. Nootropics, also known as smart drugs, are substances that are designed to improve brain function and promote neuroplasticity. The rising focus on cognitive abilities and mental health has prompted many individuals to look for natural and alternative methods of brain enhancement. Moreover, busy lifestyles and increasing workload have necessitated cognitive support, especially among professionals. As a result, nootropics supplements containing compounds such as L-theanine, caffeine, Bacopa monnieri, and phosphatidylserine are gaining significant traction globally. Furthermore, growing geriatric population susceptible to neurodegenerative disorders will continue bolstering the demand for nootropics in the upcoming years.
The global nootropics market is driven by rising health consciousness, busy lifestyles, and increased focus on cognitive abilities. However, lack of clinical evidence, stringent regulations, and potential side effects of certain compounds are limiting the market growth. Growing aging population and increased research & development activities present tremendous opportunities in the market. Rising mental health issues due to stress, anxiety, and depression have enhanced the demand for supplements supporting brain health. Additionally, advancements in delivery systems and introduction of newer compounds are further expanding the scope of the market. However, ambiguity related to dosage levels and interaction with other drugs are major challenges.
Key Features of the Study
This report provides in-depth analysis of the global nootropics market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global nootropics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Onnit Labs, Inc., Qualia (Neurohacker Collective), Nootrobox, Mind Lab Pro, Alpha Brain, Genius Consciousness, HVMN, Nootropics Depot, Neurohacker Collective, Clevor, BrainMD, Herbalife Nutrition Ltd., NOW Foods, Gaia Herbs, and Prometheus
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global nootropics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nootropics market